A combined index of waist circumference and muscle quality is associated with cardiovascular disease risk factor accumulation in Japanese obese patients: a cross-sectional study.
Cardiovascular disease
Muscle quality
Obesity, Sarcopenia
Sarcopenic obesity
Waist circumference
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
13
01
2022
accepted:
29
03
2022
pubmed:
20
4
2022
medline:
2
7
2022
entrez:
19
4
2022
Statut:
ppublish
Résumé
To identify obese patients at high risk of cardiovascular disease (CVD) using a combined index of obesity and sarcopenia. In this cross-sectional study, we firstly conducted analysis of covariance to select each index most associated with the CVD risk score, the number of concomitant CVD risk factors, among obesity- (body mass index, percentage body fat, or waist circumference [WC]) and sarcopenia-evaluated indices (skeletal muscle mass index, handgrip strength, or muscle quality [MQ]), respectively in 188 Japanese obese patients (BMI ≥ 25 kg/m WC and MQ were selected as the indices most associated with the CVD risk scores, respectively. The CVD risk score was significantly higher in Group B (low WC and low MQ) and Group D (high WC and low MQ) with higher prevalence of diabetes as compared with Group A (low WC and high MQ). Adjusted for sex and age, odds ratios for CVD risk scores = 2 were significantly higher in Group B, Group C (high WC and high MQ), and Group D compared with Group A. Furthermore, odds ratios for CVD risk scores = 3 were significantly higher only in Group D compared with Group A (4.29 [95% confidence interval: 1.49-12.33], p = 0.007). Combined index of WC and MQ was useful in Japanese obese patients at high risk of CVD, regardless sex and age.
Identifiants
pubmed: 35438441
doi: 10.1007/s12020-022-03052-5
pii: 10.1007/s12020-022-03052-5
pmc: PMC9242950
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
30-40Informations de copyright
© 2022. The Author(s).
Références
K.M. Choi, Sarcopenia and sarcopenic obesity. Korean J. Intern. Med. 31(6), 1054–1060 (2016)
pubmed: 27809450
pmcid: 5094937
doi: 10.3904/kjim.2016.193
S. Seino, S. Shinkai, K. Iijima et al. Reference values and age differences in body composition of community-dwelling older Japanese men and women: a pooled analysis of four cohort studies. PloS One 10(7), e0131975 (2015)
pubmed: 26147341
pmcid: 4492501
doi: 10.1371/journal.pone.0131975
J.A. Batsis, D.T. Villareal, Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat. Rev. Endocrinol. 14(9), 513–537 (2018)
pubmed: 30065268
pmcid: 6241236
doi: 10.1038/s41574-018-0062-9
F. Ponti, A. Santoro, D. Mercatelli et al. Aging and imaging assessment of body composition: from fat to facts. Front. Endocrinol. 10, 861 (2019)
doi: 10.3389/fendo.2019.00861
A.J. Cruz-Jentoft, G. Bahat, J. Bauer et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1), 16–31 (2019)
pubmed: 30312372
doi: 10.1093/ageing/afy169
L.-K. Chen, J. Woo, P. Assantachai et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J. Am. Med. Dir. Assoc. 21(3), 300–307. (2020)
pubmed: 32033882
doi: 10.1016/j.jamda.2019.12.012
G. Shafiee, A. Keshtkar, A. Soltani, Z. Ahadi, B. Larijani, R. Heshmat, Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J. Diabetes Metab. Disord. 16, 21 (2017)
pubmed: 28523252
pmcid: 5434551
doi: 10.1186/s40200-017-0302-x
C. Beaudart, M. Zaaria, F. Pasleau, J.-Y. Reginster, O. Bruyère, Health outcomes of sarcopenia: a systematic review and meta-analysis. PloS One 12(1), e0169548 (2017)
pubmed: 28095426
pmcid: 5240970
doi: 10.1371/journal.pone.0169548
Y. Zhang, Q. Hao, M. Ge, B. Dong, Association of sarcopenia and fractures in community-dwelling older adults: a systematic review and meta-analysis of cohort studies. Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA 29(6), 1253–1262 (2018)
doi: 10.1007/s00198-018-4429-5
S.S.Y. Yeung, E.M. Reijnierse, V.K. Pham et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J. Cachexia Sarcopenia Muscle 10(3), 485–500 (2019)
pubmed: 30993881
pmcid: 6596401
doi: 10.1002/jcsm.12411
K. Uemura, T. Doi, S. Lee, H. Shimada, Sarcopenia and low serum albumin level synergistically increase the risk of incident disability in older adults. J. Am. Med. Dir. Assoc. 20(1), 90–93 (2019)
pubmed: 30056011
doi: 10.1016/j.jamda.2018.06.011
H. Zhang, S. Lin, T. Gao et al. Association between sarcopenia and metabolic syndrome in middle-aged and older non-obese adults: a systematic review and meta-analysis. Nutrients 10(3), E364 (2018)
pubmed: 29547573
doi: 10.3390/nu10030364
S.O. Chin, S.Y. Rhee, S. Chon et al. Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PloS One 8(3), e60119 (2013)
pubmed: 23533671
pmcid: 3606314
doi: 10.1371/journal.pone.0060119
Y. Matsubara, T. Matsumoto, K. Inoue et al. Sarcopenia is a risk factor for cardiovascular events experienced by patients with critical limb ischemia. J. Vasc. Surg. 65(5), 1390–1397 (2017)
pubmed: 27986478
doi: 10.1016/j.jvs.2016.09.030
P. Liu, Q. Hao, S. Hai, H. Wang, L. Cao, B. Dong, Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas 103, 16–22 (2017)
pubmed: 28778327
doi: 10.1016/j.maturitas.2017.04.007
D. Heber, S. Ingles, J.M. Ashley, M.H. Maxwell, R.F. Lyons, R.M. Elashoff, Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. Am. J. Clin. Nutr. 64(3 Suppl), 472S–477S (1996)
pubmed: 8780366
doi: 10.1093/ajcn/64.3.472S
R.N. Baumgartner, S.J. Wayne, D.L. Waters, I. Janssen, D. Gallagher, J.E. Morley, Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. Res. 12(12), 1995–2004 (2004)
pubmed: 15687401
doi: 10.1038/oby.2004.250
Y. Rolland, V. Lauwers-Cances, C. Cristini et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am. J. Clin. Nutr. 89(6), 1895–1900 (2009)
pubmed: 19369381
doi: 10.3945/ajcn.2008.26950
C.-W. Lu, K.-C. Yang, H.-H. Chang, L.-T. Lee, C.-Y. Chen, K.-C. Huang, Sarcopenic obesity is closely associated with metabolic syndrome. Obes. Res. Clin. Pract. 7(4), e301–e307 (2013)
pubmed: 24306159
doi: 10.1016/j.orcp.2012.02.003
J. Lee, Y. Hong, H.J. Shin, W. Lee, Associations of sarcopenia and sarcopenic obesity with metabolic syndrome considering both muscle mass and muscle strength. J. Prev. Med. Public Health Yebang Uihakhoe Chi 49(1), 35–44 (2016)
pubmed: 26841883
doi: 10.3961/jpmph.15.055
J.L. Atkins, P.H. Whincup, R.W. Morris, L.T. Lennon, O. Papacosta, S.G. Wannamethee, Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J. Am. Geriatr. Soc. 62(2), 253–260 (2014)
pubmed: 24428349
doi: 10.1111/jgs.12652
T. Fukuda, R. Bouchi, T. Takeuchi et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study. Cardiovasc. Diabetol. 17(1), 55 (2018)
pubmed: 29636045
pmcid: 5891961
doi: 10.1186/s12933-018-0700-5
Evans K., Abdelhafiz D., Abdelhafiz A.H. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review. Postgrad. Med. 133(8), 831–842 (2021).
S. Tian, Y. Xu, Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr. Gerontol. Int. 16(2), 155–166 (2016)
pubmed: 26271226
doi: 10.1111/ggi.12579
D.-C. Lee, R.P. Shook, C. Drenowatz, S.N. Blair, Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism. Future Sci. OA 2(3), FSO127 (2016)
pubmed: 28031974
pmcid: 5137918
doi: 10.4155/fsoa-2016-0028
L.M. Donini, L. Busetto, J.M. Bauer, et al., Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clinical Nutr. (Edinburgh, Scotland) 39(8), 2368–2388 (2020).
doi: 10.1016/j.clnu.2019.11.024
C. Beaudart, E. McCloskey, O. Bruyère et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 16(1), 170 (2016)
pubmed: 27716195
pmcid: 5052976
doi: 10.1186/s12877-016-0349-4
Y. Yamada, M. Nishizawa, T. Uchiyama et al. Developing and validating an age-independent equation using multi-frequency bioelectrical impedance analysis for estimation of appendicular skeletal muscle mass and establishing a cutoff for sarcopenia. Int. J. Environ. Res. Public Health 14(7), E809 (2017)
pubmed: 28753945
doi: 10.3390/ijerph14070809
T.N. Kim, S.J. Yang, H.J. Yoo et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int. J. Obes. 33(8), 885–892 (2009)
doi: 10.1038/ijo.2009.130
M.A. Schrager, E.J. Metter, E. Simonsick et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J. Appl. Physiol. 102(3), 919–925 (2007)
pubmed: 17095641
doi: 10.1152/japplphysiol.00627.2006
Examination Committee of Criteria for “Obesity Disease” in Japan, Japan Society for the Study of Obesity, New criteria for “obesity disease” in Japan. Circ. J. Off. J. Jpn. Circ. Soc. 66(11), 987–992 (2002)
R. Cooper, R. Hardy, D. Bann et al. Body mass index from age 15 years onwards and muscle mass, strength, and quality in early old age: findings from the MRC National Survey of Health and Development. J. Gerontol. A. Biol. Sci. Med. Sci. 69(10), 1253–1259 (2014)
pubmed: 24682351
pmcid: 4158414
doi: 10.1093/gerona/glu039
J. Murai, H. Nishizawa, A. Otsuka et al. Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation. Cardiovasc. Diabetol. 17(1), 112 (2018)
pubmed: 30077183
pmcid: 6076400
doi: 10.1186/s12933-018-0755-3
M.J. Lees, O.J. Wilson, K. Hind, T. Ispoglou, Muscle quality as a complementary prognostic tool in conjunction with sarcopenia assessment in younger and older individuals. Eur. J. Appl. Physiol. 119(5), 1171–1181 (2019)
pubmed: 30806780
pmcid: 6469623
doi: 10.1007/s00421-019-04107-8
S. Umemura, H. Arima, S. Arima et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens. Res. 42(9), 1235–1481 (2019)
pubmed: 31375757
doi: 10.1038/s41440-019-0284-9
E. Araki, A. Goto, T. Kondo et al. Japanese clinical practice guideline for diabetes 2019. J. Diabetes Investig. 11(4), 1020–1076 (2020)
pubmed: 33021749
pmcid: 7378414
doi: 10.1111/jdi.13306
M. Kinoshita, K. Yokote, H. Arai et al. Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J. Atheroscler. Thromb. 25(9), 846–984 (2018)
pubmed: 30135334
pmcid: 6143773
doi: 10.5551/jat.GL2017
A. Hiuge-Shimizu, K. Kishida, T. Funahashi et al. Coexistence of visceral fat and multiple risk factor accumulations is strongly associated with coronary artery disease in Japanese (the VACATION-J study). J. Atheroscler. Thromb. 19(7), 657–663 (2012)
pubmed: 22472215
doi: 10.5551/jat.13037
L. Lera, C. Albala, H. Sánchez et al. Prevalence of sarcopenia in community-dwelling chilean elders according to an adapted version of the European Working Group on Sarcopenia in Older People (EWGSOP) criteria. J. Frailty Aging 6(1), 12–17 (2017)
pubmed: 28244552
L. Mosca, E. Barrett-Connor, N.K. Wenger, Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 124(19), 2145–2154 (2011)
pubmed: 22064958
pmcid: 3362050
doi: 10.1161/CIRCULATIONAHA.110.968792
A. Bosy-Westphal, C. Geisler, S. Onur et al. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int. J. Obes. 30(3), 475–483 (2006)
doi: 10.1038/sj.ijo.0803144
W. Shen, M. Punyanitya, J. Chen, et al. Waist circumference correlates with metabolic syndrome indicators better than percentage fat.Obesity (Silver Spring) 14(4), 727–736 (2006).
doi: 10.1038/oby.2006.83
Y. Cao, M. Zhong, Y. Zhang et al. Presarcopenia Is an Independent Risk Factor for Carotid Atherosclerosis in Chinese Population with Metabolic Syndrome. Diabetes Metab. Syndr. Obes. Targets Ther. 13, 81–88 (2020)
doi: 10.2147/DMSO.S235335
H. Sasaki, F. Kasagi, M. Yamada, S. Fujita, Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am. J. Med. 120(4), 337–342 (2007)
pubmed: 17398228
doi: 10.1016/j.amjmed.2006.04.018
D.P. Leong, K.K. Teo, S. Rangarajan et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet Lond. Engl 386(9990), 266–273 (2015)
doi: 10.1016/S0140-6736(14)62000-6
H. Hamasaki, Y. Kawashima, H. Katsuyama, A. Sako, A. Goto, H. Yanai, Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes. Sci. Rep. 7(1), 7041 (2017)
pubmed: 28765572
pmcid: 5539205
doi: 10.1038/s41598-017-07438-8
E. Poggiogalle, C. Lubrano, L. Gnessi et al. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity. Clin. Nutr. 38(5), 2430–2435 (2019)
pubmed: 30792144
doi: 10.1016/j.clnu.2019.01.028
V. Parcha, B. Heindl, R. Kalra et al. Insulin Resistance and Cardiometabolic Risk Profile Among Non-Diabetic American Young Adults: Insights from NHANES. J. Clin. Endocrinol. Metab. 107(1), e25–e37 (2022).
pubmed: 34473288
doi: 10.1210/clinem/dgab645
M.M. Adeva-Andany, J. Martínez-Rodríguez, M. González-Lucán, C. Fernández-Fernández, E. Castro-Quintela, Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab. Syndr. 13(2), 1449–1455 (2019)
pubmed: 31336505
doi: 10.1016/j.dsx.2019.02.023
J. Mesinovic, L.B. McMillan, C. Shore-Lorenti, B. De Courten, P.R. Ebeling, D. Scott, Metabolic Syndrome and Its Associations with Components of Sarcopenia in Overweight and Obese Older Adults. J. Clin. Med. 8(2), E145 (2019)
pubmed: 30691198
doi: 10.3390/jcm8020145
I. Reinders, R.A. Murphy, I.A. Brouwer et al. Muscle quality and myosteatosis: novel associations with mortality risk: the age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. Am. J. Epidemiol. 183(1), 53–60 (2016)
pubmed: 26643983
doi: 10.1093/aje/kwv153
R. Correa-de-Araujo, O. Addison, I. Miljkovic et al. Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging. Front. Physiol. 11, 963 (2020)
pubmed: 32903666
pmcid: 7438777
doi: 10.3389/fphys.2020.00963
Y. Akamatsu, T. Kusakabe, H. Arai et al. Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality. J. Cachexia Sarcopenia Muscle. 13(1), 180–189 (2021)
pubmed: 34845859
pmcid: 8818694
doi: 10.1002/jcsm.12860
M.S. Kirkman, V.J. Briscoe, N. Clark et al. Diabetes in Older Adults. Diabetes Care 35(12), 2650–2664 (2012)
pubmed: 23100048
pmcid: 3507610
doi: 10.2337/dc12-1801
S.W. Park, B.H. Goodpaster, E.S. Strotmeyer et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 55(6), 1813–1818 (2006)
pubmed: 16731847
doi: 10.2337/db05-1183
Atkins J.L., Wannamathee S.G. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. Br. J. Nutr. 124(10), 1102–1113 (2020)
M. Boettcher, J. Machann, N. Stefan et al. Intermuscular adipose tissue (IMAT): association with other adipose tissue compartments and insulin sensitivity. J. Magn. Reson. Imaging 29(6), 1340–1345 (2009)
pubmed: 19422021
doi: 10.1002/jmri.21754
L. Campins, M. Camps, A. Riera, E. Pleguezuelos, J.C. Yebenes, M. Serra-Prat, Oral drugs related with muscle wasting and sarcopenia. a review. Pharmacology 99(1–2), 1–8 (2017)
pubmed: 27578190
doi: 10.1159/000448247
M. König, D. Spira, I. Demuth, E. Steinhagen-Thiessen, K. Norman, Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II. J. Gerontol. 73(1), 117–122 (2017)
doi: 10.1093/gerona/glx074
S. Ishikawa, S. Naito, S. Iimori et al. Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease. PloS One 13(2), e0192990 (2018)
pubmed: 29447254
pmcid: 5814019
doi: 10.1371/journal.pone.0192990